SPRAVATO TREATMENT

Spravato treatment is a prescription-based therapy approved in the USA for adults with treatment-resistant depression and major depressive disorder with suicidal thoughts or behavior. It involves the use of a nasal spray containing esketamine, a derivative of ketamine, administered under medical supervision in certified healthcare settings. The treatment is typically combined with an oral antidepressant and follows a structured dosing schedule. Patients are monitored for potential side effects such as dizziness, sedation, or increased blood pressure. Spravato treatment offers a new approach for individuals who have not responded to conventional antidepressants, requiring strict eligibility criteria and ongoing clinical assessment.
Visit website to know more :- https://www.mymodernpsychi...